A timely update of Global COVID-19 vaccine development.

Linda Klavinskis; Margaret Liu; Shan Lu

doi:10.1080/22221751.2020.1838246

A timely update of Global COVID-19 vaccine development.

Linda Klavinskis, Margaret Liu, Shan Lu

Infectious Diseases

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

This commentary provides an overview and links to presentations of a recent virtual congress series organized by the International Society for Vaccines (ISV) focused on COVID-19 vaccines. The series provided the academic community and vaccine developers as well as the wider general public with balanced information of the global response and resources for COVID-19 vaccines under development featuring: 1) NGOs and the regulatory perspective, 2) the status of vaccine development efforts, and 3) panel discussions to present and discuss challenges. ISV is a non-profit scientific organization whose members work on all areas relevant to vaccines. ISV plans to host additional virtual symposia including regional meetings and incorporating other topics along with COVID-19 vaccines.

Original language	English
Article number	TEMI-2020-1607
Pages (from-to)	2379-2380
Number of pages	2
Journal	Emerging Infectious Diseases
Volume	9
Issue number	1
DOIs	https://doi.org/10.1080/22221751.2020.1838246
Publication status	E-pub ahead of print - 13 Oct 2020

Keywords

COVID-19
SARS-CoV-2
international society for vaccines
vaccine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/22221751.2020.1838246

Cite this

@article{deb628a2fbbb4d838746d3aa51396d49,

title = "A timely update of Global COVID-19 vaccine development.",

abstract = "This commentary provides an overview and links to presentations of a recent virtual congress series organized by the International Society for Vaccines (ISV) focused on COVID-19 vaccines. The series provided the academic community and vaccine developers as well as the wider general public with balanced information of the global response and resources for COVID-19 vaccines under development featuring: 1) NGOs and the regulatory perspective, 2) the status of vaccine development efforts, and 3) panel discussions to present and discuss challenges. ISV is a non-profit scientific organization whose members work on all areas relevant to vaccines. ISV plans to host additional virtual symposia including regional meetings and incorporating other topics along with COVID-19 vaccines.",

keywords = "COVID-19, SARS-CoV-2, international society for vaccines, vaccine",

author = "Linda Klavinskis and Margaret Liu and Shan Lu",

year = "2020",

month = oct,

day = "13",

doi = "10.1080/22221751.2020.1838246",

language = "English",

volume = "9",

pages = "2379--2380",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "1",

}

TY - JOUR

T1 - A timely update of Global COVID-19 vaccine development.

AU - Klavinskis, Linda

AU - Liu, Margaret

AU - Lu, Shan

PY - 2020/10/13

Y1 - 2020/10/13

N2 - This commentary provides an overview and links to presentations of a recent virtual congress series organized by the International Society for Vaccines (ISV) focused on COVID-19 vaccines. The series provided the academic community and vaccine developers as well as the wider general public with balanced information of the global response and resources for COVID-19 vaccines under development featuring: 1) NGOs and the regulatory perspective, 2) the status of vaccine development efforts, and 3) panel discussions to present and discuss challenges. ISV is a non-profit scientific organization whose members work on all areas relevant to vaccines. ISV plans to host additional virtual symposia including regional meetings and incorporating other topics along with COVID-19 vaccines.

AB - This commentary provides an overview and links to presentations of a recent virtual congress series organized by the International Society for Vaccines (ISV) focused on COVID-19 vaccines. The series provided the academic community and vaccine developers as well as the wider general public with balanced information of the global response and resources for COVID-19 vaccines under development featuring: 1) NGOs and the regulatory perspective, 2) the status of vaccine development efforts, and 3) panel discussions to present and discuss challenges. ISV is a non-profit scientific organization whose members work on all areas relevant to vaccines. ISV plans to host additional virtual symposia including regional meetings and incorporating other topics along with COVID-19 vaccines.

KW - COVID-19

KW - SARS-CoV-2

KW - international society for vaccines

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=85094863077&partnerID=8YFLogxK

U2 - 10.1080/22221751.2020.1838246

DO - 10.1080/22221751.2020.1838246

M3 - Article

SN - 1080-6040

VL - 9

SP - 2379

EP - 2380

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 1

M1 - TEMI-2020-1607

ER -

A timely update of Global COVID-19 vaccine development.

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this